isoquinoline-5-sulphonic acid {2-[2-(4-methoxy-benzyloxy)-ethylamino]-ethyl}-amide

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 异喹啉及其衍生物
• 英文名称: isoquinoline-5-sulphonic acid {2-[2-(4-methoxy-benzyloxy)-ethylamino]-ethyl}-amide
• 英文别名: N-[2-({2-[(4-methoxyphenyl)methoxy]ethyl}amino)ethyl]isoquinoline-5-sulfonamide；N-[2-[2-[(4-methoxyphenyl)methoxy]ethylamino]ethyl]isoquinoline-5-sulfonamide
• 化学式: C₂₁H₂₅N₃O₄S
• 分子量: 415.513
• InChiKey: HGUNWHGLYNLWEE-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2
• 重原子数：
  29
• 可旋转键数：
  11
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.29
• 拓扑面积：
  97.9
• 氢给体数：
  2
• 氢受体数：
  7

反应信息

• 作为产物：
  描述：

  N-(2-氨乙基)-5-异喹啉磺酰二盐酸盐 在 4 A molecular sieve 、 三乙酰氧基硼氢化钠 、 溶剂黄146 作用下， 以 1,2-二氯乙烷 为溶剂， 反应 3.33h， 生成 isoquinoline-5-sulphonic acid {2-[2-(4-methoxy-benzyloxy)-ethylamino]-ethyl}-amide
  参考文献：
  名称：

  蛋白激酶B的异喹啉5磺酰胺抑制剂的基于结构的设计。

  摘要：

  研究了新型PKB异喹啉5磺酰胺抑制剂作为潜在抗肿瘤药的基于结构的药物设计。鉴定并模拟了线性原型的结合构象的约束吡咯烷类似物，并通过与相关蛋白PKA的共晶体结构测定进行了研究。观察到具有相似总体构象的抑制剂之间结合模式的详细变化。该系列中的强效PKB抑制剂在细胞测定中抑制GSK3beta磷酸化，与细胞中PKB激酶活性的抑制一致。

  DOI：

  10.1016/j.bmc.2005.09.055

文献信息

• [EN] PHARMACEUTICAL COMPOUNDS<br/>[FR] COMPOSES PHARMACEUTIQUES
  申请人：ASTEX TECHNOLOGY LTD

  公开号：WO2005011697A2

  公开（公告）日：2005-02-10

  The invention provides compounds for the prophylaxis or treatment of a disease state or condition mediated by protein kinase A or protein kinase B, the compounds having the formula (I°), or being salts or solvates thereof. In formula (I°), n is 0 or 1; A and E are alkylene 2-3 carbon atoms in length optionally substituted by R11 and -X-CH(R6)(R7); G is hydrogen when n is 0 and, when n is 1, G is hydrogen or -X-CH(R6)(R7); R1 is an aryl or heteroaryl group having 5-12 ring members; R2 and R4 are selected from hydrogen, R7, R11 and CH(R6)(R7); R3, R3a and R5 are selected from hydrogen, R11 and -X-CH(R6)(R7); or any one pair or any two non-overlapping pairs selected from R2 and R3; R3 and R4; R2 and R5; R3 and R5; R4 and R5; R3 and R8; and R4 and R8 are linked together in a ring and together form an alkylene chain of 1-5 carbon atoms in length which may be optionally substituted by R11 and -X-CH(R6)(R7); or the pair R2 and R4 are linked together in a ring and together form an alkylene chain of 2-5 carbon atoms in length which may be optionally substituted by R11 and -X-CH(R6)(R7); and optionally R3 and R3a may be linked together in a ring and together form an alkylene chain of 1-6 carbon atoms in length which may be optionally substituted by R11 and -X-CH(R6)(R7); or R6 and R7 together with the carbon atom to which they are attached form a cyclic group having 5-12 ring members; X, R6, R7, R8, R9, R10 and R11 are each as defined in claim 1; and wherein the definitions of, A, E, G, X, n and R1 to R11 are subject to the provisos set ou in claim 1.